Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
08/17/2005 | EP1144385B1 Benzoheterocycles and their use as mek inhibitors |
08/17/2005 | CN1655780A Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor |
08/17/2005 | CN1654460A Continuous process for the preparation of pesticidal chlorothiazoles |
08/17/2005 | CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
08/17/2005 | CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives |
08/16/2005 | US6930131 Hetero or aromatic-alkyloxyalkylphenylsulfonamide or analogs or derivatives useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia |
08/16/2005 | US6930111 Substituted heterocyclic compounds |
08/11/2005 | WO2005073226A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
08/11/2005 | WO2005073203A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
08/11/2005 | WO2005073202A1 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors |
08/11/2005 | WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide |
08/11/2005 | WO2005072731A1 3-phenyl-n- ((1, 3, 4) thiadiazol-2-yl) -acrylamide derivatives and related compounds as modulators of estrogen-related receptors for the treatment of e.g. cancer, rheumatoid arthritis or neurological disorders |
08/11/2005 | WO2005072729A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
08/11/2005 | WO2005072681A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain. |
08/11/2005 | WO2005072132A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
08/11/2005 | WO2005058840A3 Method of coloring with capped diazotized compound and coupling component |
08/11/2005 | WO2004110983A8 New benzamides as pparϒ modulators |
08/11/2005 | WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof |
08/11/2005 | US20050176965 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors |
08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
08/11/2005 | US20050176789 Modulators of ATP-Binding Cassette transporters |
08/11/2005 | US20050176788 Such as 2-[N-(4,5-dimethoxy-2-hydroxybenzoyl)amino]-4-[(2-diisopropylaminoethyl)aminocarbonyl]-1,3-thiazole; compounds relax gastric fundus, to relieve feeling of early satiety and bloating; gastrointestinal motility disorders |
08/11/2005 | US20050176785 Process for preparing thiazole derivative and the intermediate compounds for preparing the same |
08/11/2005 | US20050176780 2,5-disubstituted 3-mercaptopentanoic acid |
08/11/2005 | US20050176776 Mitotic kinesin inhibitors |
08/11/2005 | US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors |
08/11/2005 | US20050176749 Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof |
08/11/2005 | US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime |
08/11/2005 | US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis |
08/11/2005 | US20050176709 Selective NPY (Y5) antagonists |
08/11/2005 | US20050175554 as a UV filter in cosmetic preparation; skin and hair; R3-substituted 2-(4-aminophenyl)-benzothiazole by alkylation with the appropriate haloalkanes/haloaralkanes using a base |
08/11/2005 | CA2553968A1 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
08/11/2005 | CA2551142A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
08/10/2005 | EP1318987B1 Process for resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole and compounds therefor |
08/10/2005 | EP1098891B1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
08/10/2005 | CN1653073A Substituted phenylacetic acids |
08/10/2005 | CN1653072A Broad -spectrum cephem compounds |
08/10/2005 | CN1653055A Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
08/10/2005 | CN1652780A Diaminothiazoles used as CDK4 inhibitors |
08/10/2005 | CN1652761A Preventive or therapeutic agent for kidney disease |
08/10/2005 | CN1214084C Coating composition and method for preparing the same, and scuff-resistant plastic lens |
08/10/2005 | CN1214040C Peptide derivatives having thiazolyl-alanine residue |
08/09/2005 | US6927290 Production of mixed acid anhydride and amide compound |
08/09/2005 | US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation |
08/09/2005 | US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation |
08/09/2005 | US6927224 Anticancer agents; osteoporosis |
08/09/2005 | CA2231700C Prodrugs of aspartyl protease inhibitors |
08/04/2005 | WO2005070921A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids |
08/04/2005 | WO2005070905A1 Antidiabetic oxazolidinediones and thiazolidinediones |
08/04/2005 | WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain |
08/04/2005 | WO2005070877A1 Diamino alcohols and their use as renin inhibitors |
08/04/2005 | WO2005070042A2 Novel chemical compounds |
08/04/2005 | WO2005040355A3 Tao kinase modulators and methods of use |
08/04/2005 | WO2005035489A3 Improved synthesis of discodermolide and variants thereof |
08/04/2005 | US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity |
08/04/2005 | US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity |
08/04/2005 | US20050171166 Use as inhibitors of FK560 binding proteins (FKBPs) enzyme activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injury or other related diseases |
08/04/2005 | US20050171163 MCP-1 receptor antagonists and methods of use thereof |
08/04/2005 | US20050171136 Modulators of the glucocorticoid receptor and method |
08/04/2005 | US20050171109 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
08/04/2005 | US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors |
08/04/2005 | US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile |
08/04/2005 | CA2554188A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids |
08/04/2005 | CA2553966A1 Vanilloid receptor ligands and their use in treatments |
08/04/2005 | CA2553831A1 Diamino alcohols and their use as renin inhibitors |
08/04/2005 | CA2553405A1 Antidiabetic oxazolidinediones and thiazolidinediones |
08/03/2005 | EP1559427A1 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
08/03/2005 | EP1559422A1 Receptor function controlling agent |
08/03/2005 | EP1558593A1 Transition metal catalysts for (co)polymerizing olefinic monomers |
08/03/2005 | EP1558592A1 Thiazol-(bi)cycloalkyl-carboxanilides |
08/03/2005 | EP1558576A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
08/03/2005 | CN1649859A Substituted phenylacetamides and their use as glucokinase activators |
08/03/2005 | CN1649854A Process for preparing thiazole derivative and the intermediate compounds for preparing the same |
08/03/2005 | CN1649853A Thiazolidinones compound, its preparing method and use as medicine |
08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
08/03/2005 | CN1649830A Substituted aryl ketones |
08/03/2005 | CN1649829A Novel florfenicol-type antibiotics |
08/03/2005 | CN1649586A Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
08/03/2005 | CN1649585A Epothilone derivative for the treatment of hepatoma and other cancer diseases |
08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
08/03/2005 | CN1213040C Serine protese inhibitors |
08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
08/03/2005 | CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
08/02/2005 | US6925388 Heterocyclic nonnucleoside inhibitors of reverse transcriptase |
08/02/2005 | US6924300 Oxyiminoalkanoic acid derivatives |
08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
07/28/2005 | WO2005068444A2 Thiazole derivatives and use thereof |
07/28/2005 | WO2005068443A1 Acrylonitriles and pest controlling agents |
07/28/2005 | WO2005068432A1 Malononitrile compound as pesticides |
07/28/2005 | WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
07/28/2005 | WO2005048948A3 Urea derivatives as kinase modulators |
07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
07/28/2005 | US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis |
07/28/2005 | US20050165072 used as analgesics, antiepileptics agents, antidepressants, antiarrhythmia agents and for treatment of irritable bowel syndrome, Cnohn's disease, multiple sclerosis and bipolar disorders |
07/28/2005 | US20050165069 Statine derivatives for the treatment of Alzheimer's disease |
07/28/2005 | US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide |
07/28/2005 | US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants |